These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2691474)

  • 1. The epidemiology of beta-lactamases.
    Wiedemann B; Kliebe C; Kresken M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():1-22. PubMed ID: 2691474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The threat of resistance to the new oral cephalosporins.
    Cullmann W
    Chemotherapy; 1992; 38 Suppl 2():10-7. PubMed ID: 1516458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.
    Collatz E; Labia R; Gutmann L
    Mol Microbiol; 1990 Oct; 4(10):1615-20. PubMed ID: 2077352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
    Bedenić B
    Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmid resistance to 3d generation cephalosporins].
    Philippon A; Paul G; Vedel G; Nevot P
    Presse Med; 1988 Oct; 17(37):1883-9. PubMed ID: 2973578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
    Szabó D; Barcs I; Rozgonyi F
    Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to third generation cephalosporins: the current situation.
    Pechère JC
    Infection; 1989; 17(5):333-7. PubMed ID: 2689351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative aspects of beta-lactamase production as mechanisms of beta-lactam resistance in a survey of clinical isolates from faecal samples.
    Simpson IN; Knothe H; Plested SJ; Harper PB
    J Antimicrob Chemother; 1986 Jun; 17(6):725-37. PubMed ID: 3488308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function.
    Du Bois SK; Marriott MS; Amyes SG
    J Antimicrob Chemother; 1995 Jan; 35(1):7-22. PubMed ID: 7768784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of beta-lactamase-producing pathogens.
    Acar JF; Kitzis MD; Gutmann L
    APMIS Suppl; 1989; 5():2-8. PubMed ID: 2660867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor extended-spectrum beta-lactamases.
    Naas T; Poirel L; Nordmann P
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Pseudomonas species to beta-lactam antibiotics.
    Bidwell JL; Reeves DS
    Scand J Infect Dis Suppl; 1981; 29():20-6. PubMed ID: 7031863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of enzymatic resistance to beta-lactam antibiotics].
    Philippon A; Paul G; Nevot P
    Presse Med; 1986 Dec; 15(46):2290-6. PubMed ID: 2949270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
    Schito GC; Pesce A; Debbia EA
    Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance of gram negative bacteria to new generation cephalosporins and the role of beta-lactamases in this type of resistance].
    Gür D; Akalin HE; Baykal M
    Mikrobiyol Bul; 1988; 22(3):193-8. PubMed ID: 3266970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current aspects of bacterial resistance to antibiotics].
    Brisson-Noel A; Trieu-Cuot P; Sougakoff W; Courvalin P
    Ann Biol Clin (Paris); 1989; 47(2):98-101. PubMed ID: 2660637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of bacterial resistance to antibiotics.
    Dever LA; Dermody TS
    Arch Intern Med; 1991 May; 151(5):886-95. PubMed ID: 2025137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W; Dick W; Stieglitz M; Opferkuch W
    Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of ceftazidime in regard to different classes of beta-lactamases. The situation in 1988].
    Labia R; Barthélémy M; Peduzzi J; Morand A; Tiwari K
    Presse Med; 1988 Oct; 17(37):1890-4. PubMed ID: 2973579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.